Questioning the Ban: E-cigarette Regulation in Argentina

Aug.15.2023
Questioning the Ban: E-cigarette Regulation in Argentina
Argentine e-cigarette association questions government regulations, claiming e-cigarettes reduce tobacco risks by 95%, calling for independent regulation.

According to Argentine media outlet Eleconomista, on August 14th, the Argentine e-cigarette association has raised concerns about the government's regulation policies on e-cigarettes. While acknowledging that e-cigarettes are not completely harmless, the association argues that for those who are unable or unwilling to quit smoking, e-cigarettes can reduce the risks associated with traditional tobacco by 95%. As a result, they are calling for independent regulation that does not treat e-cigarettes on par with traditional tobacco.


Approximately one million Argentines are currently using e-cigarettes.


E-cigarettes and heated tobacco products are gaining popularity worldwide, not only among those seeking non-combustible and lower nicotine options, but also among people who enjoy inhaling nicotine-free flavored vapor.


In Argentina, the use of these products has not been legally sanctioned, and it is estimated that there are currently around one million people nationwide using e-cigarettes.


However, since 2011, the sales, importation, distribution, promotion, and advertising of e-cigarettes have been prohibited according to the regulations set by the National Administration of Food, Drugs, and Medical Technology (ANMAT). Additionally, the Ministry of Health has banned the use of heated tobacco products starting from March 2023.


Compared to traditional cigarette smoking, the nicotine and approximately 7000 toxic substances in cigarettes are highly addictive and can potentially cause respiratory diseases, cardiovascular ailments, and various types of cancer, including lung, throat, and laryngeal cancers.


According to statistics released by the Ministry of Health in Argentina, 22.2% of adults over the age of 18 are smokers. Approximately 45,000 people die each year due to smoking, accounting for 14% of the total number of deaths.


Cigarette smoking continues to raise concerns every year due to its detrimental impact on health. Recent statistics reveal notable consequences, including 19,000 cancer diagnoses, 33,000 cases of pneumonia, 11,000 strokes, 61,000 hospitalizations caused by cardiovascular diseases, and over 100,000 new cases of chronic obstructive pulmonary disease (COPD).


Call for independent regulation.


An e-cigarette, formally known as a Nicotine Electronic Aerosolization System (SEAN) or a Non-Nicotine Electronic Aerosolization System (SESN), is a battery-operated device that heats a solution composed of propylene glycol, glycerin, and potentially flavorings to 250 degrees Celsius, producing an aerosol for consumer inhalation.


Furthermore, the heating of specially crafted tobacco leaves and pods containing nicotine in heated tobacco products (HTPs), without combustion, has been deemed toxic and carcinogenic by the World Health Organization (WHO). Therefore, the WHO states that HTPs should be regulated as "other products within the tobacco category" due to a lack of sufficient data indicating that they are less harmful than traditional cigarettes.


The Ministry of Health in Argentina has implemented strict regulations on e-cigarettes and PTC due to concerns about their potential health risks and addictive behavior.


However, the Argentine e-cigarette association acknowledges that e-cigarettes are not entirely harmless but claims that they reduce the risks associated with traditional tobacco by 95% for individuals who cannot or do not want to quit smoking.


As a result, they are calling for independent regulation and not treating it on par with traditional tobacco.


Juan Facundo Teme, chairman of the association, believes that the use of e-cigarettes in Argentina has been stigmatized. He is urging the government to study regulatory measures in countries like the United Kingdom and questions why prohibition is the only option for Latin American countries.


References: When writing articles or reports, it is crucial to include references to support the information provided. References serve as sources of evidence and credibility for the claims made in the piece. They allow readers to verify the information themselves and ensure accuracy. Citing references also demonstrates the author's research and diligence in gathering information from reliable sources. This adds depth and authority to the piece, increasing its reliability and trustworthiness. In academic writing, referencing is considered a standard practice, as it gives credit to the original authors and acknowledges their contributions to the field. It also helps to avoid plagiarism by clearly attributing ideas and information to their rightful owners. Proper referencing involves providing complete and accurate information about the sources used, including the author's name, publication date, title, and relevant details. Different citation styles, such as MLA, APA, and Chicago, have specific rules and formats for referencing various types of sources, such as books, journals, websites, and interviews. Including references in a written piece not only strengthens its credibility but also encourages further exploration and research on the subject matter. It allows readers to delve deeper into the topic and engage with the material on a more scholarly level. In conclusion, references play a vital role in journalistic writing. They elevate the quality and reliability of the piece, ensure accuracy, and recognize the contributions of others. By including proper references, writers demonstrate their commitment to intellectual honesty and integrity.


Vaping in Argentina: Is its prohibition reasonable?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
Kantar Study Finds More Than 93% of Vape Products in Ukraine Fail Regulatory Requirements
According to Interfax-Ukraine, a study conducted by market research firm Kantar Ukraine at the request of major tobacco companies found that more than 93% of vape products in Ukraine did not fully comply with regulatory requirements. The research examined product categories, brand distribution and consumer purchasing channels, showing that pod systems and disposable vapes represent major segments of the market, while offline retail remains the dominant purchasing channel. The findings highlight ongoing compliance challenges in Ukraine’s vape market.
Aug.26
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
Philip Morris International (PMI) showcased IQOS heated tobacco systems and nicotine pouch products at Technovation 2026 in Buenos Aires on October 7–8, presenting research on consumer attitudes, regulatory developments and illicit cigarette trade across Latin America. PMI Chief Global Growth Officer Stefano Volpetti said smoke-free products accounted for more than 7% of the Mexico City market. Argentina repealed its heated tobacco ban in May 2026 and introduced registration requirements for tobacco and nicotine products, while local media reported nicotine pouch sales in Mendoza. A PMI-commissioned survey found that only 8% of respondents across four Latin American countries were familiar with nicotine pouches. A separate KPMG study estimated illicit cigarette consumption at 77 billion sticks across 11 markets in Latin America and Canada in 2025.
PMI
Oct.13
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20